Omega Healthcare Investors (NYSE:OHI) Price Target Raised to $37.00

Omega Healthcare Investors (NYSE:OHI) had its target price boosted by Mizuho from $35.00 to $37.00 in a report published on Thursday,Benzinga reports. They currently have a neutral rating on the real estate investment trust’s stock.

A number of other equities analysts also recently commented on OHI. Royal Bank of Canada increased their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 price target on the stock. Scotiabank upped their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $40.18.

Omega Healthcare Investors Price Performance

NYSE OHI opened at $39.25 on Thursday. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The firm has a market capitalization of $10.60 billion, a price-to-earnings ratio of 28.86, a price-to-earnings-growth ratio of 1.23 and a beta of 0.98. The company has a 50 day simple moving average of $40.48 and a 200-day simple moving average of $37.65. Omega Healthcare Investors has a 52-week low of $27.53 and a 52-week high of $44.42.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.83%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s payout ratio is 197.06%.

Insider Buying and Selling

In other news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Institutional Trading of Omega Healthcare Investors

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Assetmark Inc. boosted its stake in Omega Healthcare Investors by 1.7% in the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock valued at $48,492,000 after acquiring an additional 19,542 shares during the last quarter. BNP Paribas Financial Markets boosted its position in shares of Omega Healthcare Investors by 120.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust’s stock worth $9,212,000 after purchasing an additional 123,836 shares during the last quarter. Daiwa Securities Group Inc. grew its stake in shares of Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the period. Caxton Associates LP bought a new stake in Omega Healthcare Investors in the second quarter valued at about $1,652,000. Finally, Van ECK Associates Corp lifted its stake in Omega Healthcare Investors by 15.4% in the third quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust’s stock valued at $4,167,000 after buying an additional 13,367 shares during the period. 65.25% of the stock is currently owned by institutional investors and hedge funds.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.